LeRoy LeNarz

Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease

David E. Kandzari, Martin B. Leon, Jeffrey J. Popma et al. · Journal of the American College of Cardiology · 2006 · 346 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +7

Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort

Peter K. Smith, Lawrence T. Goodnough, Jerrold H. Levy et al. · Journal of the American College of Cardiology · 2012 · 199 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Mortality Benefit +6

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials

A. Michael Lincoff, LeRoy LeNarz, George J. Despotis et al. · The Annals of Thoracic Surgery · 2000 · 92 citations · Full text

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +13

Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI

Gilles Montalescot, Jean‐Philippe Collet, Patrick Ecollan et al. · Journal of the American College of Cardiology · 2014 · 73 citations · Full text

Percutaneous Coronary Intervention, Cardiovascular Disease, Prasugrel Pre-treatment Strategy +7

Improved graft patency associated with altered platelet function induced by marine fatty acids in dogs

Robert E. Casali, Janet A. Hale, LeRoy LeNarz et al. · Journal of Surgical Research · 1986 · 45 citations

Thrombopoiesis, Altered Platelet Function, Blood Platelet +4